Company Overview and News


Add VICL
to your dashboard

Headline News

BRIEF-‍Stonepine Capital Management reports 6.6 pct passive stake in Vical

2017-11-15 reuters
* ‍Stonepine Capital Management Llc reports 6.6 percent passive stake in Vical Inc as on November 8, 2017 - SEC filing​ Source text: (bit.ly/2z2Y7Nh) Further company coverage: (3-1)

VICL / Vical Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-09 fintel.io
Vical Inc. (NASDAQ:VICL) has 35 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,690,677 shares. Largest shareholders include FMR LLC / Fidelity Management & Research, Renaissance Technologies LLC, Ariel Investments, Llc, BlackRock Inc., and New York State Common Retirement Fund. (35-0)

Vical Incorporated's (VICL) CEO Vijay Samant on Q3 2017 Results - Earnings Call Transcript

2017-10-23 seekingalpha
Good day, ladies and gentlemen, and welcome the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference is being recorded, and that all participants are in a listen-only-mode. At the request of the Company, we will open up the conference up for questions from invited guests at the end of presentation. (18-1)

BRIEF-Vical Inc files for common stock offering of up to $23.0 mln

2017-10-16 reuters
* Vical Inc files for common stock offering of up to $23.0 million - SEC filing‍​ Source: (bit.ly/2gnoSUA) Further company coverage: (3-0)

Vical Incorporated's (VICL) CEO Vijay Samant on Q2 2017 Results - Earnings Call Transcript

2017-08-08 seekingalpha
Good day and welcome ladies and gentlemen to the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference call is being recorded, and that all participants are in a listen-only mode. At the request of the Company, we will open up the conference up for question-and-answers from invited participants after the presentation.

Vical's (VICL) CEO Vijay Samant on Q1 2017 Results - Earnings Call Transcript

2017-05-15 seekingalpha
Good day, ladies and gentlemen. And welcome to the Vical Q1 Earnings 2017 Conference Call. At this time, I would like to inform you that this conference call is being recorded, and that all participants are in a listen-only mode. At the request of the Company, we will open up the conference up for question-and -answers from invited participants after the presentation.

Investor Network Invites You to the Vical First Quarter 2017 Earnings Webcast Live on Monday, May 15, 2017

2017-05-12 accesswire
SAN DIEGO, CA / ACCESSWIRE / May 12, 2017 / Vical Incorporated (NASDAQ: VICL) will host a live webcast to discuss the results of the first quarter 2017, to be held Monday, May 15, 2017, 2017 at 12:00 PM Eastern Time.

Vical's (VICL) CEO Vijay Samant on Q4 2016 Results - Earnings Call Transcript

2017-03-10 seekingalpha
Good day, and welcome ladies and gentlemen to the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference is being recorded, and that all participants are in a listen-only mode. At the request of the Company, we will open up the conference up for question-and -answers from invited participants after the presentation.

Investor Network Invites You to the Vical Fourth Quarter 2016 Earnings Webcast Live on Thursday, March 9, 2017

2017-03-08 accesswire
SAN DIEGO, CA / ACCESSWIRE / March 8, 2017 / Vical Incorporated (NASDAQ: VICL) will host a live webcast to discuss the results of the fourth quarter 2016, to be held Thursday, March 9, 2017 at 12:00 PM Eastern Time.

Vical: A Risky Net-Net Provides The Potential For A Profitable Swing Trade

2017-01-10 seekingalpha
Vical (NASDAQ:VICL) has been a horror show for investors. Failed trials, poor technology and a lack of awareness have left this small biotech company from San Diego all but forgotten. There are many reasons that a long-term investor would have no interest in this company even though it passes Benjamin Graham's criteria as a net-net investment because it is trading below cash. I believe there might be one or two more puffs left in this old cigar butt investment if you put a swing trade spin on it. (0-1)

Neurocrine Biosciences Stock Could See A Run-Up

2016-11-09 seekingalpha
Neurocrine Biosciences has several upcoming catalysts, including PDUFA for Valbenazine (in Tardive dyskinesia) in April, 2017 and planned NDA for elagolix in endometriosis (AbbVie) in 2017.

Vical's (VICL) CEO Vijay Samant on Q3 2016 Results - Earnings Call Transcript

2016-11-04 seekingalpha
Good day, and welcome ladies and gentlemen to the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference is being recorded, and that all participants are in a listen-only mode. At the request of the Company, we will open up the conference up for question and answers from invited participants after the presentation.

Vical Slumps, Cytomegalovirus Vaccine Fails in Phase II Study

2016-09-21 zacks
Vical Incorporated (VICL - Snapshot Report) and partner Astellas Pharma, Inc. announced disappointing top-line data from a phase II study on their experimental cytomegalovirus (CMV) vaccine candidate, ASP0113, in kidney transplant patients. Vical’s shares plunged 22.3% on the news.

Vical's (VICL) CEO Vijay Samant on Q4 2015 Results - Earnings Call Transcript

2016-09-20 seekingalpha
Please standby, we are about to begin. Good day, and welcome ladies and gentlemen to the Vical Incorporated Financial Results Conference Call. At this time, I would like to inform you that this conference is being recorded, and then all participants are in a listen-only mode. At the request of the company, we will open the conference for questions and answers for invited participants after the presentation.

CUSIP: 925602203